Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Defines the base value in index calculation and explains its role as the reference point for all subsequent index levels.
21,618 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Dan Ives of Wedbush argues the AI revolution is still in its early innings, signaling multi-year upside for Nvidia an...
When a stock pulls back from its highs, investors want to know if the drop is a buying signal or a warning. This guid...
A white-hat researcher retrieved 1,003.62 ETH from a 2016 Ethereum ICO contract, reviving debate over early design ch...
Two real estate giants are dueling over how data is distributed. As Compass leans on MLS access to push its agenda, o...
Five-year losses on laddered bonds have stretched retirees' portfolios. If Kevin Warsh takes the helm, his policy cho...
Variant has closed a $222 million fund to back early-stage startups at the intersection of AI, crypto, and autonomy. ...
Investors nudged Intel higher after AI infrastructure news signaled stronger demand for its CPU and accelerator lineu...
Major crypto assets slumped in a broad selloff, with Bitcoin and peers posting double-digit declines as market sentim...
Tech stocks lead market declines as traders weigh higher-for-longer rates against cooling AI chip enthusiasm and a su...
Markets waver as the administration frames Iran tension as a military exercise, even as missiles and drones test secu...
XRP faces a pivotal week after slipping to the $1 level as sellers test support. This week’s ripple (xrp) price predi...